Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients. Teniente-Serra A, Hervás J V, Quirant-Sánchez B, Mansilla M J, Grau-López L, Ramo-Tello C, Martínez-Cáceres E M CNS Neurosci Ther. 2016 Apr 15. PMID: 27080413. Abstract CommentRecommendBookmarkWatch